ALB and Rare hereditary thrombophilia: Clinical decision-making should incorporate a comprehensive assessment of patient-specific factors, including comorbidities (e.g., renal impairment, thrombophilia), pregnancy status, nutritional status (albumin <3.0 g/dl), and religious objections to plasma-derived products.